Effects of hyperbaric oxygen on symptoms and quality of life among service members with persistent postconcussion symptoms: a randomized clinical trial
R Scott Miller,Lindell K Weaver,Nazanin Bahraini,Susan Churchill,Robert C Price,Virginia Skiba,James Caviness,Scott Mooney,Brian Hetzell,Jun Liu,Kayla Deru,Richard Ricciardi,Susan Fracisco,Nicole C Close,Gerald W Surrett,Corinna Bartos,Margaret Ryan,Lisa A Brenner,HOPPS Trial Team,Kate Hak,Heidi Terrio,Laura Grogan,Mike Anderson,Simon Robertson,Jason Gordon,Dan Lesley,Tom Johnson,Dawn Mitchell,Peter Zamfirescu,Scott Sparks,Illy Dominitz,Stephen Fischer,Jason Roby,James Chung,Lisa Tangredi,William Howes,Joel Raintree,Michael Madsen,Jack Rigg,Austin Chhoeu,Otto Boneta,Eric Helling,Eric Martin,Herb Yeager,Matthew Salak,Maria Devore,Leah Russell,Jami Egan,Mark Greeder,Jennifer Gardino,Caron Wilbur,Kris Spalloni,Tiffany Cripps,Ashlea Raynor,Karen Bartku,Linda Corkhill,Delia Marshall,Kilwanna Bush-Brown,Nancy Sickafoose,Rachael Anderson,Alayna Capo,Dana Hahn,Phil Treadway,Debbie Treadway,John Gross,Robert Samonte,James Rife,Michael Eastman,Dustin Halper,Eddie Johnson,Mike Fogie,Arturo Morales,Carlos Lewis,Daniel Jarmillo,Nicole Garrett,Preston Burrell,Cheryl Dicks,Belinda Wagner,Kevin Marrs,Lorena DiRienzo,Melissa Askin,Shannon Berg,Ernest Yribe,Kirsten Smith,Jim Bell,Brendan Murphy,Devin Hunt,Dixion Rwaksyaguri,Doug Domalik,Kyle Martin,Ilka DeLeon,Krista Mormon,Christie Lawrence
DOI: https://doi.org/10.1001/jamainternmed.2014.5479
Abstract:Importance: Improvement has been anecdotally observed in patients with persistent postconcussion symptoms (PCS) after mild traumatic brain injury following treatment with hyperbaric oxygen (HBO). The effectiveness of HBO as an adjunctive treatment for PCS is unknown to date. Objectives: To compare the safety of and to estimate the efficacy for symptomatic outcomes from standard PCS care alone, care supplemented with HBO, or a sham procedure. Design, setting, and participants: Multicenter, double-blind, sham-controlled clinical trial of 72 military service members with ongoing symptoms at least 4 months after mild traumatic brain injury enrolled at military hospitals in Colorado, North Carolina, California, and Georgia between April 26, 2011, and August 24, 2012. Assessments occurred before randomization, at the midpoint, and within 1 month after completing the interventions. Interventions: Routine PCS care was provided in specialized clinics. In addition, participants were randomized 1:1:1 to 40 HBO sessions administered at 1.5 atmospheres absolute (ATA), 40 sham sessions consisting of room air at 1.2 ATA, or no supplemental chamber procedures. Main outcomes and measures: The Rivermead Post-Concussion Symptoms Questionnaire (RPQ) served as the primary outcome measure. A change score of at least 2 points on the RPQ-3 subscale (range, 0-12) was defined as clinically significant. Change scores from baseline were calculated for the RPQ-3 and for the total RPQ. Secondary measures included additional patient-reported outcomes and automated neuropsychometric testing. Results: On average, participants had sustained 3 lifetime mild traumatic brain injuries; the most recent occurred 23 months before enrollment. No differences were observed between groups for improvement of at least 2 points on the RPQ-3 subscale (25% in the no intervention group, 52% in the HBO group, and 33% in the sham group; P = .24). Compared with the no intervention group (mean change score, 0.5; 95% CI, -4.8 to 5.8; P = .91), both groups undergoing supplemental chamber procedures showed improvement in symptoms on the RPQ (mean change score, 5.4; 95% CI, -0.5 to 11.3; P = .008 in the HBO group and 7.0; 95% CI, 1.0-12.9; P = .02 in the sham group). No difference between the HBO group and the sham group was observed (P = .70). Chamber sessions were well tolerated. Conclusions and relevance: Among service members with persistent PCS, HBO showed no benefits over sham compressions. Both intervention groups demonstrated improved outcomes compared with PCS care alone. This finding suggests that the observed improvements were not oxygen mediated but may reflect nonspecific improvements related to placebo effects. Trial registration: clinicaltrials.gov Identifier: NCT01306968.